Adverse skin lesions after methylene blue injections for sentinel lymph node localization

American Journal of Surgery

Volumn 184, Issue 4, 2002, Pages 350-352

  Stradling, Benjamin ^a   Aranha, Gerard ^b   Gabram, Sheryl ^b  

^a MIDWESTERN UNIVERSITY   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Methylene blue dye; Sentinel lymph node

Indexed keywords

METHYLENE BLUE; SULFADIAZINE SILVER;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BREAST SURGERY; BREAST TUMOR; CLINICAL ARTICLE; CONTROLLED STUDY; DEBRIDEMENT; HUMAN; PARENCHYMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE; SKIN DEFECT; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INJECTIONS, INTRADERMAL; METHYLENE BLUE; MIDDLE AGED; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SKIN DISEASES;

EID: 0036803439     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(02)00945-5     Document Type: Article

References (15)

1. McMasters K.M., Guiliano A.E., Ross M.I., et al. Sentinel lymph node biopsy for breast cancer - not yet the standard of care. N Engl J Med. 339:1998;990-995.
2. Giuliano A., Kirgan D., Guenther M., Morton D. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 220:1994;391-398.
3. Kern K.A. Breast lymphatic mapping using subareolar injections of blue dye and radiocolloid illustrated technique. J Am Coll Surg. 192:2001;545-550.
4. Simmons R.M., Rosenbaum Smith S.M., Osborne M.P. Methylene blue dye as an alternative to isosulfan blue dye for sentinel lymph node localization. Breast J. 7:2001;181-183.
5. Sadiq T.S., Burns W.W., Taber D.J., et al. Blue urticaria a previously unreported adverse event associated with isosulfan blue. Arch Surg. 136:2001;1433-1435.
6. Cimmino V.M., Brown A.C., Szocik J.F., et al. Allergic reactions to isosulfan blue during sentinel node biopsy - a common event. Surgery. 130:2001;439-442.
7. Perry P.M., Meinhard E. Necrotic subcutaneous abscesses following injections of methylene blue. Br J Clin Pract. 28:1974;289-291.
8. Ruhlen J.L. Tissue necrosis cutaneous and subcutaneous damage following extravasation of methylene blue. J Kansas Med Soc. 83:1982;236-251.
9. Farouk R., Lee P.W.R. Intradermal methylene blue injection for the treatment of intractable idiopathic pruritis ani. Br J Surg. 84:1997;670.
10. Eusebio E.B., Graham J., Mody N. Treatment of intractable pruritis ani. Dis Colon Rectum. 33:1990;770-772.
11. Johnson P.C., Sheppeck R. The dark side of methylene blue. Plast Reconstr Surg. 83:1989;1076-1077.
12. Lane K.L., Vallera R., Washington K., Gottfried M.R. Endoscopic tattoo agents in the colon tissue responses and clinical implications. Am J Surg Pathol. 20:1996;1266-1270.
13. Sharr M.M., Weller R.O., Brice J.G. Spinal cord necrosis after intrathecal injection of methylene blue. J Neurol Neurosurg Psychiatry. 41:1978;384-386.
14. McEnerney J.K., McEnerney L.N. Unfavorable neonatal outcome after injection of methylene blue. Obstet Gynecol. 61:1983;35S-37S.
15. Brownstein S., Liszauer A.D., Jackson W.B. Ocular complications of a topical methylene blue-vasoconstrictor-anesthetic preparation. Can J Ophthalmol. 24:1989;317-324.